Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan J Collins

Showing results (81-90 of 268) with videos related to

Pageof 27
Sort By:
Kidney International|September 18, 2002
A comparison of transplant outcomes in peritoneal and hemodialysis patientsJon J Snyder, Bertram L Kasiske, David T Gilbertson, et al.
Advances in Renal Replacement Therapy|January 20, 2004
Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factorsSuying Li, Donna D McAlpine, Jiannong Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizationsJames P Ebben, David T Gilbertson, Robert N Foley, et al.
Journal of the American Society of Nephrology : JASN|January 26, 2007
Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United StatesBlanche M Chavers, Craig A Solid, David T Gilbertson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2008
Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?Charles A Herzog, Jeremy W Strief, Allan J Collins, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2014
Relative safety of peginesatide and epoetin alfaEric D Weinhandl, David T Gilbertson, Allan J Collins, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 24, 2004
Long-term survival of dialysis patients with bacterial endocarditis in the United StatesGautam R Shroff, Charles A Herzog, Jennie Z Ma, et al.
Kidney International|December 1, 2004
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysisEdward F Vonesh, Jon J Snyder, Robert N Foley, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 10, 2007
Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003Craig A Solid, Robert N Foley, David T Gilbertson, et al.
Kidney International Supplements|June 23, 2015
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal diseaseAllan J Collins, Robert N Foley, David T Gilbertson, et al.
Pageof 27

Showing results (81-90 of 268) with videos related to

Sort By:
Pageof 27
Kidney International|September 18, 2002
A comparison of transplant outcomes in peritoneal and hemodialysis patientsJon J Snyder, Bertram L Kasiske, David T Gilbertson, et al.
Advances in Renal Replacement Therapy|January 20, 2004
Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factorsSuying Li, Donna D McAlpine, Jiannong Liu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizationsJames P Ebben, David T Gilbertson, Robert N Foley, et al.
Journal of the American Society of Nephrology : JASN|January 26, 2007
Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United StatesBlanche M Chavers, Craig A Solid, David T Gilbertson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2008
Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?Charles A Herzog, Jeremy W Strief, Allan J Collins, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2014
Relative safety of peginesatide and epoetin alfaEric D Weinhandl, David T Gilbertson, Allan J Collins, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 24, 2004
Long-term survival of dialysis patients with bacterial endocarditis in the United StatesGautam R Shroff, Charles A Herzog, Jennie Z Ma, et al.
Kidney International|December 1, 2004
The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysisEdward F Vonesh, Jon J Snyder, Robert N Foley, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 10, 2007
Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003Craig A Solid, Robert N Foley, David T Gilbertson, et al.
Kidney International Supplements|June 23, 2015
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal diseaseAllan J Collins, Robert N Foley, David T Gilbertson, et al.
Pageof 27